The purpose of this module is to provide advanced detailed knowledge of disorders within the areas of benign haematology and haemostasis, with an emphasis on their clinical and laboratory investigation. Disease pathophysiology and current and emerging therapies will also be discussed.
*Curricular information is subject to change
- Anaemia; Erythropoiesis, nutritional anaemias, haemolytic anaemias; red cell membrane disorders and enzyme deficiencies
- Disorders of Haemoglobin; Quantitative and qualitative disorders of haemoglobin, their pathophysiology, identification, quantitation and treatment
- Haematological Aspects of Tropical Disease; Disease examples such as malaria, filariasis, sleeping sickness, chagas disease, leishmaniasis
- Benign White Cell Disorders; A selection of inherited and acquired non-malignant white cell disorders
- Recent developments in understanding Haemostatic Pathways; Endothelial and platelet activation, coagulation, fibrinolysis, regulatory and inhibitory pathways, inflammation
- Inherited and acquired Bleeding Disorders; Clinical features and laboratory investigation, emerging therapies, relevant guidelines
- Thrombotic Disorders; Clinical features and laboratory investigation, emerging therapies, relevant guidelines
- Platelets; Platelets in pregnancy, cardiac disease, bacterial interactions, platelet function assays, anti-platelet therapy, POCT
- Anticoagulants; Recent developments in anticoagulant therapy, reversal agents, laboratory monitoring and limitations
Lectures, tutorials, student presentations, case studies, workshops, paper reviews.
| Module Content & Assessment | |
|---|---|
| Assessment Breakdown | % |
| Formal Examination | 60 |
| Other Assessment(s) | 40 |